Prosecution Insights
Prosecution Insights
10 pending office actions • 8 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (10%) |
| Double-patenting + other | 3 (30%) |
| Multi-statute (no §101) | 6 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUMPHRIES, NICHOLAS ADAM | 2 | 33.3% | +78.6% |
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
| HUDSON, AMY ROSE | 1 | 75.0% | +11.4% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 60.0% | +48.2% |
| O'NEILL, MARISOL ANN | 1 | 54.8% | +63.6% |
| MARVICH, MARIA | 1 | 54.7% | +28.1% |
| LAFAVE, ELIZABETH ROSE | 1 | 58.3% | +46.6% |
| HOLLAND, PAUL J | 1 | 57.3% | +64.7% |
| SALVOZA, M FRANCO G | 1 | 68.7% | +29.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797633 | METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS | O'NEILL, MARISOL ANN | 60d overdue |
| 18019421 | METHODS OF TREATING CARDIAC DISORDERS AND CONGESTIVE HEART FAILURE AND ADMINISTERING AAV VECTORS | VIJAYARAGHAVAN, JAGAMYA NMN | 32d overdue |
| 17293861 | VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TARGETING SEQUENCE | SALVOZA, M FRANCO G | 17d overdue |
| 17620557 | PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION | HOLLAND, PAUL J | 16d |
| 18572668 | REGULATORY NUCLEIC ACID SEQUENCES | BEHARRY, ZANNA MARIA | — |
| 18286709 | RATIONAL POLYPLOID AAV VIRIONS THAT CROSS THE BLOOD BRAIN BARRIER AND ELICIT REDUCED HUMORAL RESPONSE | HUMPHRIES, NICHOLAS ADAM | — |
| 17787898 | METHOD FOR IDENTIFYING REGULATORY ELEMENTS | LAFAVE, ELIZABETH ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797633 | METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS | O'NEILL, MARISOL ANN | 60d overdue |
| 18019421 | METHODS OF TREATING CARDIAC DISORDERS AND CONGESTIVE HEART FAILURE AND ADMINISTERING AAV VECTORS | VIJAYARAGHAVAN, JAGAMYA NMN | 32d overdue |
| 17293861 | VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TARGETING SEQUENCE | SALVOZA, M FRANCO G | 17d overdue |
| 17620557 | PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION | HOLLAND, PAUL J | 16d |
| 18572668 | REGULATORY NUCLEIC ACID SEQUENCES | BEHARRY, ZANNA MARIA | — |
| 18286709 | RATIONAL POLYPLOID AAV VIRIONS THAT CROSS THE BLOOD BRAIN BARRIER AND ELICIT REDUCED HUMORAL RESPONSE | HUMPHRIES, NICHOLAS ADAM | — |
| 18027293 | METHODS FOR TREATING NEUROLOGICAL DISEASE | HUDSON, AMY ROSE | — |
| 17907229 | INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION | HUMPHRIES, NICHOLAS ADAM | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1633 | 2 |
| 1632 | 1 |
| 1636 | 1 |
| 1634 | 1 |
| 1684 | 1 |
| 1656 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18572668 | REGULATORY NUCLEIC ACID SEQUENCES | BEHARRY, ZANNA MARIA | 1632 | §102§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18286709 | RATIONAL POLYPLOID AAV VIRIONS THAT CROSS THE BLOOD BRAIN BARRIER AND ELICIT REDUCED HUMORAL RESPONSE | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18027293 | METHODS FOR TREATING NEUROLOGICAL DISEASE | HUDSON, AMY ROSE | 1636 | §103§112DP | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18019421 | METHODS OF TREATING CARDIAC DISORDERS AND CONGESTIVE HEART FAILURE AND ADMINISTERING AAV VECTORS | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §102§103§112 | Final Rejection | 32d overdue | Pending | Feb 02, 2023 |
| 17907229 | INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112DP | Final Rejection | — | Pending | Sep 23, 2022 |
| 17797633 | METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS | O'NEILL, MARISOL ANN | 1633 | §103§112 | Non-Final OA | 60d overdue | Pending | Aug 04, 2022 |
| 17856187 | MODIFIED SOLUBLE VEGF RECEPTOR-1 GENES AND VECTORS FOR GENE THERAPY | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Jul 01, 2022 |
| 17787898 | METHOD FOR IDENTIFYING REGULATORY ELEMENTS | LAFAVE, ELIZABETH ROSE | 1684 | §103§112 | Non-Final OA | — | Pending | Jun 21, 2022 |
| 17620557 | PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION | HOLLAND, PAUL J | 1656 | §102§103 | Final Rejection | 16d | Pending | Dec 17, 2021 |
| 17293861 | VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TARGETING SEQUENCE | SALVOZA, M FRANCO G | 1672 | §102§103§112Other | Non-Final OA | 17d overdue | Pending | May 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial